Industry group responds to Dutch Minister’s 'something’s gotta give' reaction to drug price increases

A Dutch biopharma trade group has proposed a summit with the government on drug price transparency in response to Minister of Health Bruno Bruins’ threat to name and shame companies that excessively raise drug prices. The move by Bruins was intended to spur companies to be more transparent in their drug pricing and justify any major increases.

In the Netherlands, the price for high cost medicines is often undisclosed and is based on negotiations between the company and the Office of Price Negotiation at the Ministry of Health...